Press Release: Peripheral Vascular Device Market Report 2024-2034

30 April 2024.

The global Peripheral Vascular Devices market is estimated at US$12.49 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

Press Release: Drug Delivery Technologies Market Report 2024-2034

23 April 2024.

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

18 April 2024.

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

17 April 2024.

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

12 April 2024.

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

11 April 2024.

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

Visiongain Publishes Female Health Tech Market Report 2024-2034

5 April 2024.

The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.

Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034

26 March 2024.

The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034

Visiongain Publishes Medical Imaging Devices Market Report 2024-2034

20 March 2024.

The global Medical Imaging Devices market was valued at US$ 54.3 billion in 2024 and is projected to grow at a CAGR of 4.6% during the forecast period 2024-2034.

Visiongain Publishes Women’s Health Market Report 2024-2034

18 March 2024.

The global Women’s Health market was estimated to be valued at US$ 61 billion in 2034 and is expected to register a CAGR of 4.6% from 2024 to 2034.

Visiongain Publishes Clinical Trial Supplies Market Report 2024-2034

14 March 2024.

The global Clinical Trial Supplies market is estimated at US$4,146.7 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period 2024-2034.

Visiongain Publishes Pre-Filled Syringes Market Report 2024-2034

The global Pre-Filled Syringes market is estimated at US$5,069.3 million in 2024 and is expected to register a CAGR of 9.5% from 2024 to 2034.

Visiongain Publishes Generic Drugs Market Report 2024-2034

The global Generic Drugs market is estimated at US$450.7 billion in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period 2024-2034.

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2024-2034

The global Pharma Wholesale and Distribution market is estimated at US$844.2 billion in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.

Visiongain Publishes Biobanking Market Report 2024-2034

The global Biobanking market is estimated at US$75.4 billion in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period 2024-2034.

Visiongain Publishes Dermatological Drugs Market Report 2024-2034

The Dermatological Drugs market is estimated at US$30.47 billion in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period 2024-2034.

Visiongain Publishes Allergic Rhinitis Drugs Market Report 2024-2034

The global Allergic Rhinitis Drugs market is estimated at US$16,821.6 million in 2024 and is expected to register a CAGR of 2.7% from 2024 to 2034.

Visiongain Publishes Translational Regenerative Medicine Market Report 2024-2034

The global Translational Regenerative Medicine market is estimated at US$77.93 billion in 2024 and is expected to register a CAGR of 24.3% from 2024 to 2034.

Visiongain Publishes Epilepsy Therapeutics Market Report 2024-2034

The global Epilepsy Therapeutics market is estimated at US$9,858.7 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period 2024-2034.

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2024-2034

The global Companion Diagnostics (CDx) market is estimated at US$6,574.6 million in 2024 and is projected to grow at a CAGR of 11% during the forecast period 2024-2034.

Clients & Partners

Deloitte logo
BAE systems logo
DUPONT logo
3M logo
BP logo
Daimler logo
Kelloggs logo
Honeywell logo
Lockhead Martin logo
Raytheon logo
Pfizer logo
TEVA logo
BAYER logo
THALES logo
Unilever logo